SPDR S&P Biotech (XBI) 68.27 $XBI
SPDR S&P Biotech ETF Falls 2.15% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Nov 12, 6:54PM CST
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $68.15 to a high of $70.00. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $69.65 on volume of 3.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 68.27 (-0.05)
Buy Amgen's Healthy Dividend, Hold for Its Growth Prescription
at The Street - Tue Nov 10, 6:05AM CST
Amgen's dividend may be just on par with the S&P 500's average, but its forward earnings ratio and price target make it a solid buy-and-hold candidate.
BIIB: 284.84 (-6.49), XBI: 68.27 (-0.05), ALXN: 166.44 (+0.31), AMGN: 151.55 (+0.57)
Top ETF Stories to Watch for in November
Zacks Equity Research - Zacks Investment Research - Wed Nov 04, 11:22AM CST
Inside the top financial stories and their impact on the world of ETFs which could be in watch in November.
BSJG: 26.03 (-0.03), KRE: 43.79 (-0.60), EUSC: 24.94 (-0.03), SBIO: 31.44 (+0.47), CNXT: 41.11 (-1.72), XBI: 68.27 (-0.05), ECNS: 43.86 (-1.54), UUP: 25.76 (+0.09), HEWG: 24.77 (-0.12)
After Yesterday's Rally of 6.56% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Nov 02, 4:15PM CST
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $66.63 to a high of $71.10. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $70.12 on volume of 4.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 68.27 (-0.05)
The Top 3 Biotech ETFs on the Market
Brian Feroldi, The Motley Fool - Motley Fool - Sun Nov 01, 3:09PM CST
Photo by Bill Brooks Flickr Creative Commons. Biotech investing is not for the faint of heart . The industry is chock-full of companies that don't even have revenue yet, let alone profits, which can lead to wild price swings. To make matters...
FBT: 107.45 (+1.01), XBI: 68.27 (-0.05), IBB: 323.64 (+3.53)
Look for Shares of SPDR S&P Biotech ETF to Potentially Pullback after Yesterday's 2.19% Rise
Comtex SmarTrend(R) - Tue Oct 27, 4:25PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $65.70 to a high of $67.35. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $67.30 on volume of 4.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 68.27 (-0.05)
Downtrend Call Working As SPDR S&P Biotech ETF Stock Falls 9.0% (XBI)
Comtex SmarTrend(R) - Thu Oct 22, 9:43AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 4 weeks, SPDR S&P Biotech ETF has returned 9.01% as of today's recent price of $63.65.
XBI: 68.27 (-0.05)
Shareholder Alert: 4 Stocks Ready to Make a Move
ACCESSWIRE - Mon Oct 19, 11:17AM CDT
WINDSOR, ONTARIO / ACCESSWIRE / October 19, 2015 / The Wealthy Biotech Trader (or "WBT"
, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma, medical device and general healthcare stocks making news and subsequent market moves, is alerting traders about several trade ideas within the very healthy medical device sector.
LOXO: 28.15 (+0.41), XBI: 68.27 (-0.05), FORD: 1.37 (-0.03)
Watch for SPDR S&P Biotech ETF to Potentially Rebound After Falling 4.41% Yesterday
Comtex SmarTrend(R) - Tue Oct 13, 4:00PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $61.16 to a high of $65.20. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $61.38 on volume of 5.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 68.27 (-0.05)
SPDR S&P Biotech ETF Down 7.4% Since SmarTrend Downtrend Call (XBI)
Comtex SmarTrend(R) - Tue Oct 13, 11:54AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 3 weeks, SPDR S&P Biotech ETF has returned 7.38% as of today's recent price of $64.79.
XBI: 68.27 (-0.05)
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
Zacks Equity Research - Zacks Investment Research - Mon Oct 12, 8:30AM CDT
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
SPXU: 33.59 (+1.08), SH: 21.22 (+0.23), SDS: 20.67 (+0.46), XBI: 68.27 (-0.05), IBB: 323.64 (+3.53)
Protea: A High Quality Small-Cap to Ride Out Biotech's Drop
ACCESSWIRE - Mon Oct 12, 8:16AM CDT
REDONDO BEACH, CA / ACCESSWIRE / October 12, 2015 / The SPDR S&P Biotech ETF (ARCA: XBI) has fallen more than 20% over the past three months, which significantly outpaced the S&P 500's 4.7% fall over the same timeframe. With the House of Representatives subpoenaing Valeant Pharmaceuticals International Inc. (NYSE: VRX) for documents related to drug price increases, the market is concerned that the federal government may be stepping up its efforts to curb increases in drug prices.
VRX: 75.41 (+1.64), FMI: 16.58 (+0.61), XBI: 68.27 (-0.05), WAT: 128.69 (-0.76), VRX.TO: 100.53 (+2.39)
Juno Therapeutics (JUNO) Stock Could Lead the Way to a Biotech Bounce
at The Street - Fri Oct 09, 10:40AM CDT
We're watching the SPDR S&P Biotech ETF and its components for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 68.27 (-0.05), JUNO: 50.00 (+0.11)
Charting a Biotech Bounce
at The Street - Fri Oct 09, 10:10AM CDT
We're watching the SPDR S&P Biotech ETF for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 68.27 (-0.05), JUNO: 50.00 (+0.11)
7 Huge Mistakes Every ETF Investor Needs to Avoid
Eric Dutram - Zacks Investment Research - Fri Oct 09, 9:45AM CDT
These are some of the most common misconceptions about ETF investing, make sure you do not make the same mistakes!
SPY: 202.54 (-2.30), VXX: 21.96 (+1.40), GLD: 103.56 (-0.29), XBI: 68.27 (-0.05), IBB: 323.64 (+3.53), IAU: 10.45 (-0.02)
Correction in Health Care Stocks Remains in Full Force
at The Street - Thu Oct 08, 3:00PM CDT
Have we reached the point where something will be done about it?
CI: 131.57 (+0.18), ANTM: 132.55 (-0.88), HCA: 66.45 (+1.34), XBI: 68.27 (-0.05), UNH: 111.41 (-1.41), IBB: 323.64 (+3.53), XLV: 69.57 (-0.17)
3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical
Sean Williams, The Motley Fool - Motley Fool - Wed Oct 07, 7:03AM CDT
Source: Federal Reserve Bank of New York. With the exception of the last couple of weeks, the biotech sector has been a vast outperformer since the Great Recession. The broad-based S&P 500 has pretty much tripled since hitting its lows in...
BIIB: 284.84 (-6.49), VRTX: 123.05 (+5.75), XBI: 68.27 (-0.05), INCY: 107.36 (+3.16)
SPDR S&P Biotech ETF Rises 4.89% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 02, 4:07PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $60.45 to a high of $65.75. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $64.56 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 68.27 (-0.05)
SPDR S&P Biotech ETF Falls 2.15% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Nov 12, 6:54PM CST
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $68.15 to a high of $70.00. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $69.65 on volume of 3.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 68.27 (-0.05)
Buy Amgen's Healthy Dividend, Hold for Its Growth Prescription
at The Street - Tue Nov 10, 6:05AM CST
Amgen's dividend may be just on par with the S&P 500's average, but its forward earnings ratio and price target make it a solid buy-and-hold candidate.
BIIB: 284.84 (-6.49), XBI: 68.27 (-0.05), ALXN: 166.44 (+0.31), AMGN: 151.55 (+0.57)
Top ETF Stories to Watch for in November
Zacks Equity Research - Zacks Investment Research - Wed Nov 04, 11:22AM CST
Inside the top financial stories and their impact on the world of ETFs which could be in watch in November.
BSJG: 26.03 (-0.03), KRE: 43.79 (-0.60), EUSC: 24.94 (-0.03), SBIO: 31.44 (+0.47), CNXT: 41.11 (-1.72), XBI: 68.27 (-0.05), ECNS: 43.86 (-1.54), UUP: 25.76 (+0.09), HEWG: 24.77 (-0.12)
After Yesterday's Rally of 6.56% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Nov 02, 4:15PM CST
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $66.63 to a high of $71.10. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $70.12 on volume of 4.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 68.27 (-0.05)
The Top 3 Biotech ETFs on the Market
Brian Feroldi, The Motley Fool - Motley Fool - Sun Nov 01, 3:09PM CST
Photo by Bill Brooks Flickr Creative Commons. Biotech investing is not for the faint of heart . The industry is chock-full of companies that don't even have revenue yet, let alone profits, which can lead to wild price swings. To make matters...
FBT: 107.45 (+1.01), XBI: 68.27 (-0.05), IBB: 323.64 (+3.53)
Look for Shares of SPDR S&P Biotech ETF to Potentially Pullback after Yesterday's 2.19% Rise
Comtex SmarTrend(R) - Tue Oct 27, 4:25PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $65.70 to a high of $67.35. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $67.30 on volume of 4.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 68.27 (-0.05)
Downtrend Call Working As SPDR S&P Biotech ETF Stock Falls 9.0% (XBI)
Comtex SmarTrend(R) - Thu Oct 22, 9:43AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 4 weeks, SPDR S&P Biotech ETF has returned 9.01% as of today's recent price of $63.65.
XBI: 68.27 (-0.05)
Shareholder Alert: 4 Stocks Ready to Make a Move
ACCESSWIRE - Mon Oct 19, 11:17AM CDT
WINDSOR, ONTARIO / ACCESSWIRE / October 19, 2015 / The Wealthy Biotech Trader (or "WBT"
, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma, medical device and general healthcare stocks making news and subsequent market moves, is alerting traders about several trade ideas within the very healthy medical device sector. LOXO: 28.15 (+0.41), XBI: 68.27 (-0.05), FORD: 1.37 (-0.03)
Watch for SPDR S&P Biotech ETF to Potentially Rebound After Falling 4.41% Yesterday
Comtex SmarTrend(R) - Tue Oct 13, 4:00PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $61.16 to a high of $65.20. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $61.38 on volume of 5.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 68.27 (-0.05)
SPDR S&P Biotech ETF Down 7.4% Since SmarTrend Downtrend Call (XBI)
Comtex SmarTrend(R) - Tue Oct 13, 11:54AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 3 weeks, SPDR S&P Biotech ETF has returned 7.38% as of today's recent price of $64.79.
XBI: 68.27 (-0.05)
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
Zacks Equity Research - Zacks Investment Research - Mon Oct 12, 8:30AM CDT
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
SPXU: 33.59 (+1.08), SH: 21.22 (+0.23), SDS: 20.67 (+0.46), XBI: 68.27 (-0.05), IBB: 323.64 (+3.53)
Protea: A High Quality Small-Cap to Ride Out Biotech's Drop
ACCESSWIRE - Mon Oct 12, 8:16AM CDT
REDONDO BEACH, CA / ACCESSWIRE / October 12, 2015 / The SPDR S&P Biotech ETF (ARCA: XBI) has fallen more than 20% over the past three months, which significantly outpaced the S&P 500's 4.7% fall over the same timeframe. With the House of Representatives subpoenaing Valeant Pharmaceuticals International Inc. (NYSE: VRX) for documents related to drug price increases, the market is concerned that the federal government may be stepping up its efforts to curb increases in drug prices.
VRX: 75.41 (+1.64), FMI: 16.58 (+0.61), XBI: 68.27 (-0.05), WAT: 128.69 (-0.76), VRX.TO: 100.53 (+2.39)
Juno Therapeutics (JUNO) Stock Could Lead the Way to a Biotech Bounce
at The Street - Fri Oct 09, 10:40AM CDT
We're watching the SPDR S&P Biotech ETF and its components for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 68.27 (-0.05), JUNO: 50.00 (+0.11)
Charting a Biotech Bounce
at The Street - Fri Oct 09, 10:10AM CDT
We're watching the SPDR S&P Biotech ETF for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 68.27 (-0.05), JUNO: 50.00 (+0.11)
7 Huge Mistakes Every ETF Investor Needs to Avoid
Eric Dutram - Zacks Investment Research - Fri Oct 09, 9:45AM CDT
These are some of the most common misconceptions about ETF investing, make sure you do not make the same mistakes!
SPY: 202.54 (-2.30), VXX: 21.96 (+1.40), GLD: 103.56 (-0.29), XBI: 68.27 (-0.05), IBB: 323.64 (+3.53), IAU: 10.45 (-0.02)
Correction in Health Care Stocks Remains in Full Force
at The Street - Thu Oct 08, 3:00PM CDT
Have we reached the point where something will be done about it?
CI: 131.57 (+0.18), ANTM: 132.55 (-0.88), HCA: 66.45 (+1.34), XBI: 68.27 (-0.05), UNH: 111.41 (-1.41), IBB: 323.64 (+3.53), XLV: 69.57 (-0.17)
3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical
Sean Williams, The Motley Fool - Motley Fool - Wed Oct 07, 7:03AM CDT
Source: Federal Reserve Bank of New York. With the exception of the last couple of weeks, the biotech sector has been a vast outperformer since the Great Recession. The broad-based S&P 500 has pretty much tripled since hitting its lows in...
BIIB: 284.84 (-6.49), VRTX: 123.05 (+5.75), XBI: 68.27 (-0.05), INCY: 107.36 (+3.16)
SPDR S&P Biotech ETF Rises 4.89% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 02, 4:07PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $60.45 to a high of $65.75. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $64.56 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 68.27 (-0.05)
